Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Nov 1;166(5):1329–1350. doi: 10.1084/jem.166.5.1329

Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition

PMCID: PMC2189648  PMID: 2445888

Abstract

We have investigated the role of the carbohydrate moiety on the HLA-B7 molecule in mAb and CTL recognition using oligonucleotide-directed mutagenesis and gene transfer techniques. A conservative substitution of asparagine to glutamine at amino acid 86 in HLA-B7 was created to abolish the unique glycosylation site present on all HLA molecules. A second mutant B7 molecule was made by substituting asparagine-aspartic acid-threonine for the resident lysine-aspartic acid/lysine tripeptide at amino acids 176-178, thus creating an N-linked glycan at amino acid 176, which is additionally present on all known murine H-2 class I antigens. Upon gene transfer into mouse and human cell recipients, the HLA-B7M176+ mutant and normal HLA-B7 expressed identical levels of surface protein. However, the binding of two mAbs (MB40.2 and MB40.3) thought to recognize different epitopes of the HLA-B7 molecule was completely eliminated. In contrast, the HLA-B7M86- mutant displayed no surface expression (mouse L cells) or minimal surface expression (human RD cells or mouse L cells coexpressing human beta 2 microglobulin [beta 2m]) after indirect immunofluorescence (IIF) and flow cytometric analysis with a panel of 12 HLA-B7 mAb reactive with monomorphic and polymorphic determinants. Immunoprecipitation analysis demonstrated that intracellular denatured mutant protein was present. Tunicamycin treatment did not rescue the expression of HLA-B7M86- antigens to the cell surface; while interferon did induce higher levels of surface expression. Tunicamycin treatment also did not allow binding of the mAbs MB40.2 or MB40.3 to HLA-B7M176+ mutant antigens, suggesting that the carbohydrate moiety itself was not directly involved in the recognition or conformation of these mAb epitopes. Further mutation of the B7M86- molecule to create a glycan moiety at amino acid position 176 (B7M86-/176+) did not rescue normal levels of surface expression. Finally, neither mutation was seen to affect recognition by a panel of 12 allospecific CTL clones. The low expression of HLA-B7M86- on the surface of human cell transfectants was sufficient to achieve lysis, albeit at a reduced efficiency, and lysis could be increased by interferon induction of higher levels of expression. Thus, the carbohydrate moiety on HLA antigens plays a minimal or nonexistent role in recognition by available mAb and allospecific CTL clones.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbosa J. A., Mentzer S. J., Kamarck M. E., Hart J., Biro P. A., Strominger J. L., Burakoff S. J. Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. J Immunol. 1986 Apr 15;136(8):3085–3091. [PubMed] [Google Scholar]
  2. Barbosa J. A., Mentzer S. J., Minowada G., Strominger J. L., Burakoff S. J., Biro P. A. Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7549–7553. doi: 10.1073/pnas.81.23.7549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Black P. L., Vitetta E. S., Forman J., Kang C. Y., May R. D., Uhr J. W. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells. Eur J Immunol. 1981 Jan;11(1):48–55. doi: 10.1002/eji.1830110111. [DOI] [PubMed] [Google Scholar]
  5. Braciale T. J. Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells. J Exp Med. 1977 Sep 1;146(3):673–689. doi: 10.1084/jem.146.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brodsky F. M., Parham P., Barnstable C. J., Crumpton M. J., Bodmer W. F. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3–61. doi: 10.1111/j.1600-065x.1979.tb00288.x. [DOI] [PubMed] [Google Scholar]
  7. Brondz B. D., Snegiröva A. E., Rassulin Y. A., Shamborant O. G. Modification of in vitro immune lymphocyte-target cell interaction by some biologically active drugs. Immunochemistry. 1973 Mar;10(3):175–189. doi: 10.1016/0019-2791(73)90006-2. [DOI] [PubMed] [Google Scholar]
  8. Chen E. Y., Seeburg P. H. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA. 1985 Apr;4(2):165–170. doi: 10.1089/dna.1985.4.165. [DOI] [PubMed] [Google Scholar]
  9. Colombani J., Dausset J., Lepage V., Degos L., Kalil J., Fellous M. HLA monoclonal antibody registry: a proposal. Tissue Antigens. 1982 Sep;20(3):161–171. doi: 10.1111/j.1399-0039.1982.tb00342.x. [DOI] [PubMed] [Google Scholar]
  10. Engelhard V. H., Yannelli J. R., Evans G. A., Walk S. F., Holterman M. J. Construction of novel class I histocompatibility antigens by interspecies exon shuffling. J Immunol. 1985 Jun;134(6):4218–4225. [PubMed] [Google Scholar]
  11. Fuhrmann U., Bause E., Ploegh H. Inhibitors of oligosaccharide processing. Biochim Biophys Acta. 1985 Jun 24;825(2):95–110. doi: 10.1016/0167-4781(85)90095-8. [DOI] [PubMed] [Google Scholar]
  12. Goldstein S. A., Mescher M. F. Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes. J Exp Med. 1985 Oct 1;162(4):1381–1386. doi: 10.1084/jem.162.4.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grunstein M., Hogness D. S. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961–3965. doi: 10.1073/pnas.72.10.3961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guan J. L., Machamer C. E., Rose J. K. Glycosylation allows cell-surface transport of an anchored secretory protein. Cell. 1985 Sep;42(2):489–496. doi: 10.1016/0092-8674(85)90106-0. [DOI] [PubMed] [Google Scholar]
  15. Hart G. W. The role of asparagine-linked oligosaccharides in cellular recognition by thymic lymphocytes. Effects of tunicamycin on the mixed lymphocyte reaction. J Biol Chem. 1982 Jan 10;257(1):151–158. [PubMed] [Google Scholar]
  16. Ito H., Ike Y., Ikuta S., Itakura K. Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support. Nucleic Acids Res. 1982 Mar 11;10(5):1755–1769. doi: 10.1093/nar/10.5.1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kavathas P., Herzenberg L. A. Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A. 1983 Jan;80(2):524–528. doi: 10.1073/pnas.80.2.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kimball E. S., Coligan J. E. Structure of class I major histocompatibility antigens. Contemp Top Mol Immunol. 1983;9:1–63. doi: 10.1007/978-1-4684-4517-6_1. [DOI] [PubMed] [Google Scholar]
  19. Kramer W., Drutsa V., Jansen H. W., Kramer B., Pflugfelder M., Fritz H. J. The gapped duplex DNA approach to oligonucleotide-directed mutation construction. Nucleic Acids Res. 1984 Dec 21;12(24):9441–9456. doi: 10.1093/nar/12.24.9441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Krangel M. S., Orr H. T., Strominger J. L. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell. 1979 Dec;18(4):979–991. doi: 10.1016/0092-8674(79)90210-1. [DOI] [PubMed] [Google Scholar]
  21. Lopez de Castro J. A., Barbosa J. A., Krangel M. S., Biro P. A., Strominger J. L. Structural analysis of the functional sites of class I HLA antigens. Immunol Rev. 1985 Jul;85:149–168. doi: 10.1111/j.1600-065x.1985.tb01134.x. [DOI] [PubMed] [Google Scholar]
  22. MacDonald H. R., Cerottini J. C. Inhibition of T cell-mediated cytolysis by 2-deoxy-D-glucose:dissociation of the inhibitory effect from glycoprotein synthesis. Eur J Immunol. 1979 Jun;9(6):466–470. doi: 10.1002/eji.1830090610. [DOI] [PubMed] [Google Scholar]
  23. Machamer C. E., Florkiewicz R. Z., Rose J. K. A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol. 1985 Nov;5(11):3074–3083. doi: 10.1128/mcb.5.11.3074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Maziarz R., Allen H., Strominger J. L., Flavell R., Biro P. A., Burakoff S. J. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6276–6280. doi: 10.1073/pnas.82.18.6276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mentzer S. J., Barbosa J. A., Strominger J. L., Biro P. A., Burakoff S. J. Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. J Immunol. 1986 Jul 15;137(2):408–413. [PubMed] [Google Scholar]
  26. Miyazaki J., Appella E., Zhao H., Forman J., Ozato K. Expression and function of a nonglycosylated major histocompatibility class I antigen. J Exp Med. 1986 Apr 1;163(4):856–871. doi: 10.1084/jem.163.4.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Muirhead K. A., Schmitt T. C., Muirhead A. R. Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. Cytometry. 1983 Jan;3(4):251–256. doi: 10.1002/cyto.990030404. [DOI] [PubMed] [Google Scholar]
  28. Murre C., Choi E., Weis J., Seidman J. G., Ozato K., Liu L., Burakoff S. J., Reiss C. S. Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains. J Exp Med. 1984 Jul 1;160(1):167–178. doi: 10.1084/jem.160.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parham P., Alpert B. N., Orr H. T., Strominger J. L. Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation. J Biol Chem. 1977 Nov 10;252(21):7555–7567. [PubMed] [Google Scholar]
  30. Parham P., Antonelli P., Herzenberg L. A., Kipps T. J., Fuller A., Ward F. E. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol. 1986 Jan;15(1):44–67. doi: 10.1016/0198-8859(86)90316-2. [DOI] [PubMed] [Google Scholar]
  31. Parham P. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies. J Immunol. 1984 Jun;132(6):2975–2983. [PubMed] [Google Scholar]
  32. Parham P. Monoclonal antibodies against two separate alloantigenic sites of HLA-B40. Immunogenetics. 1981;13(6):509–527. doi: 10.1007/BF00343719. [DOI] [PubMed] [Google Scholar]
  33. Ploegh H. L., Orr H. T., Stominger J. L. Biosynthesis and cell surface localization of nonglycosylated human histocompatibility antigens. J Immunol. 1981 Jan;126(1):270–275. [PubMed] [Google Scholar]
  34. Ploegh H. L., Orr H. T., Strominger J. L. Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell. 1981 May;24(2):287–299. doi: 10.1016/0092-8674(81)90318-4. [DOI] [PubMed] [Google Scholar]
  35. Rebaï N., Malissen B. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens. 1983 Aug;22(2):107–117. doi: 10.1111/j.1399-0039.1983.tb01176.x. [DOI] [PubMed] [Google Scholar]
  36. Reiss C. S., Evans G. A., Margulies D. H., Seidman J. G., Burakoff S. J. Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proc Natl Acad Sci U S A. 1983 May;80(9):2709–2712. doi: 10.1073/pnas.80.9.2709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Santos-Aguado J., Biro P. A., Fuhrmann U., Strominger J. L., Barbosa J. A. Amino acid sequences in the alpha 1 domain and not glycosylation are important in HLA-A2/beta 2-microglobulin association and cell surface expression. Mol Cell Biol. 1987 Mar;7(3):982–990. doi: 10.1128/mcb.7.3.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shiroishi T., Evans G. A., Appella E., Ozato K. In vitro mutagenesis of a mouse MHC class I gene for the examination of structure-function relationships. J Immunol. 1985 Jan;134(1):623–629. [PubMed] [Google Scholar]
  39. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  40. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982;1(4):327–341. [PubMed] [Google Scholar]
  41. Stanley P. Membrane mutants of animal cells: rapid identification of those with a primary defect in glycosylation. Mol Cell Biol. 1985 May;5(5):923–929. doi: 10.1128/mcb.5.5.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Todd R. F., 3rd Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. III. Enzyme sensitivity of target cell antigens. Cell Immunol. 1975 Dec;20(2):257–268. doi: 10.1016/0008-8749(75)90103-3. [DOI] [PubMed] [Google Scholar]
  43. Yang S. Y., Morishima Y., Collins N. H., Alton T., Pollack M. S., Yunis E. J., Dupont B. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics. 1984;19(3):217–231. doi: 10.1007/BF00364765. [DOI] [PubMed] [Google Scholar]
  44. Zoller M. J., Smith M. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol. 1983;100:468–500. doi: 10.1016/0076-6879(83)00074-9. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES